VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model

Yoshihisa Sakai, Steven Goodison, Wengang Cao, Virginia Urquidi, Kazunori Namiki, Stacy Porvasnik, Cydney Urbanek, Charles Joel Rosser

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: We have previously demonstrated that prostate tumors that highly express Bcl-2 are not only more tumorigenic, but also more angiogenic than low Bcl-2 expressing tumors. Observed increased rates of angiogenesis are likely due to the secretion of multiple factors from the tumor cells. Experimental design: Human endothelial cells were subjected to exogenous VEGF or conditioned media from PC-3 cells and assayed by several in vitro systems to better characterize the effects of tumor microenvironment on endothelial cells. Results: VEGF stimulation increased Bcl-2 expression in human microvascular endothelial cells (HMVECs), at least partially through stabilization of Bcl-2 mRNA transcripts, and protected these cells from apoptosis. These effects were mimicked by treatment of HMVECs with conditioned media from cultured PC-3 prostate tumor cells manipulated to overexpress Bcl-2. Through the use of kinase inhibitors and molecular profiling, several distinct pathways were implicated in the regulation of Bcl-2 in HMVECs, including those involving PI3K/AKT, PKC, mTOR, STAT-1, and IL-8, factors associated with tumor survival and growth. Conclusions: This study identifies molecular elements of a link between Bcl-2 expression in distinct cell types within a tumor and reaffirms that strategies designed to target Bcl-2 are desirable as they might enhance treatment response through dual effects.

Original languageEnglish (US)
Pages (from-to)659-666
Number of pages8
JournalWorld Journal of Urology
Volume27
Issue number5
DOIs
StatePublished - Jun 8 2009
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Prostatic Neoplasms
Endothelial Cells
Neoplasms
Conditioned Culture Medium
Prostate
Tumor Microenvironment
Interleukin-8
Phosphatidylinositol 3-Kinases
Research Design
Phosphotransferases
Apoptosis
Messenger RNA
Survival
Growth

Keywords

  • Angiogenesis
  • Bcl-2
  • Cancer
  • Gene expression
  • Prostate
  • VEGF

ASJC Scopus subject areas

  • Urology

Cite this

VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model. / Sakai, Yoshihisa; Goodison, Steven; Cao, Wengang; Urquidi, Virginia; Namiki, Kazunori; Porvasnik, Stacy; Urbanek, Cydney; Rosser, Charles Joel.

In: World Journal of Urology, Vol. 27, No. 5, 08.06.2009, p. 659-666.

Research output: Contribution to journalArticle

Sakai, Yoshihisa ; Goodison, Steven ; Cao, Wengang ; Urquidi, Virginia ; Namiki, Kazunori ; Porvasnik, Stacy ; Urbanek, Cydney ; Rosser, Charles Joel. / VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model. In: World Journal of Urology. 2009 ; Vol. 27, No. 5. pp. 659-666.
@article{c5a4f850cb1c462c96d983fb75f42f13,
title = "VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model",
abstract = "Purpose: We have previously demonstrated that prostate tumors that highly express Bcl-2 are not only more tumorigenic, but also more angiogenic than low Bcl-2 expressing tumors. Observed increased rates of angiogenesis are likely due to the secretion of multiple factors from the tumor cells. Experimental design: Human endothelial cells were subjected to exogenous VEGF or conditioned media from PC-3 cells and assayed by several in vitro systems to better characterize the effects of tumor microenvironment on endothelial cells. Results: VEGF stimulation increased Bcl-2 expression in human microvascular endothelial cells (HMVECs), at least partially through stabilization of Bcl-2 mRNA transcripts, and protected these cells from apoptosis. These effects were mimicked by treatment of HMVECs with conditioned media from cultured PC-3 prostate tumor cells manipulated to overexpress Bcl-2. Through the use of kinase inhibitors and molecular profiling, several distinct pathways were implicated in the regulation of Bcl-2 in HMVECs, including those involving PI3K/AKT, PKC, mTOR, STAT-1, and IL-8, factors associated with tumor survival and growth. Conclusions: This study identifies molecular elements of a link between Bcl-2 expression in distinct cell types within a tumor and reaffirms that strategies designed to target Bcl-2 are desirable as they might enhance treatment response through dual effects.",
keywords = "Angiogenesis, Bcl-2, Cancer, Gene expression, Prostate, VEGF",
author = "Yoshihisa Sakai and Steven Goodison and Wengang Cao and Virginia Urquidi and Kazunori Namiki and Stacy Porvasnik and Cydney Urbanek and Rosser, {Charles Joel}",
year = "2009",
month = "6",
day = "8",
doi = "10.1007/s00345-009-0422-0",
language = "English (US)",
volume = "27",
pages = "659--666",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model

AU - Sakai, Yoshihisa

AU - Goodison, Steven

AU - Cao, Wengang

AU - Urquidi, Virginia

AU - Namiki, Kazunori

AU - Porvasnik, Stacy

AU - Urbanek, Cydney

AU - Rosser, Charles Joel

PY - 2009/6/8

Y1 - 2009/6/8

N2 - Purpose: We have previously demonstrated that prostate tumors that highly express Bcl-2 are not only more tumorigenic, but also more angiogenic than low Bcl-2 expressing tumors. Observed increased rates of angiogenesis are likely due to the secretion of multiple factors from the tumor cells. Experimental design: Human endothelial cells were subjected to exogenous VEGF or conditioned media from PC-3 cells and assayed by several in vitro systems to better characterize the effects of tumor microenvironment on endothelial cells. Results: VEGF stimulation increased Bcl-2 expression in human microvascular endothelial cells (HMVECs), at least partially through stabilization of Bcl-2 mRNA transcripts, and protected these cells from apoptosis. These effects were mimicked by treatment of HMVECs with conditioned media from cultured PC-3 prostate tumor cells manipulated to overexpress Bcl-2. Through the use of kinase inhibitors and molecular profiling, several distinct pathways were implicated in the regulation of Bcl-2 in HMVECs, including those involving PI3K/AKT, PKC, mTOR, STAT-1, and IL-8, factors associated with tumor survival and growth. Conclusions: This study identifies molecular elements of a link between Bcl-2 expression in distinct cell types within a tumor and reaffirms that strategies designed to target Bcl-2 are desirable as they might enhance treatment response through dual effects.

AB - Purpose: We have previously demonstrated that prostate tumors that highly express Bcl-2 are not only more tumorigenic, but also more angiogenic than low Bcl-2 expressing tumors. Observed increased rates of angiogenesis are likely due to the secretion of multiple factors from the tumor cells. Experimental design: Human endothelial cells were subjected to exogenous VEGF or conditioned media from PC-3 cells and assayed by several in vitro systems to better characterize the effects of tumor microenvironment on endothelial cells. Results: VEGF stimulation increased Bcl-2 expression in human microvascular endothelial cells (HMVECs), at least partially through stabilization of Bcl-2 mRNA transcripts, and protected these cells from apoptosis. These effects were mimicked by treatment of HMVECs with conditioned media from cultured PC-3 prostate tumor cells manipulated to overexpress Bcl-2. Through the use of kinase inhibitors and molecular profiling, several distinct pathways were implicated in the regulation of Bcl-2 in HMVECs, including those involving PI3K/AKT, PKC, mTOR, STAT-1, and IL-8, factors associated with tumor survival and growth. Conclusions: This study identifies molecular elements of a link between Bcl-2 expression in distinct cell types within a tumor and reaffirms that strategies designed to target Bcl-2 are desirable as they might enhance treatment response through dual effects.

KW - Angiogenesis

KW - Bcl-2

KW - Cancer

KW - Gene expression

KW - Prostate

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=70349482521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349482521&partnerID=8YFLogxK

U2 - 10.1007/s00345-009-0422-0

DO - 10.1007/s00345-009-0422-0

M3 - Article

VL - 27

SP - 659

EP - 666

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 5

ER -